BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: You J, Sriplung H, Geater A, Chongsuvivatwong V, Zhuang L, Chen HY, Yu L, Tang BZ, Huang JH. Effect of viral load on T-lymphocyte failure in patients with chronic hepatitis B. World J Gastroenterol 2008; 14(7): 1112-1119 [PMID: 18286696 DOI: 10.3748/wjg.14.1112]
URL: https://www.wjgnet.com/1007-9327/full/v14/i7/1112.htm
Number Citing Articles
1
Y. Shi, Y. Lan, F. Cao, Y. Teng, L. Li, F. Wang, J. Li, J. Zhou, Y. Li. Infected hematopoietic stem cells and with integrated HBV DNA generate defective T cells in chronic HBV infection patientsJournal of Viral Hepatitis 2014; 21(7) doi: 10.1111/jvh.12236
2
Mingtao Quan, Lezhi Li, Xiaoli Yuan, Zhixia Jiang, Xuyao Wang, Hualian Wu, Xiaojuan Li. Influence of multiple factors on the incidence of occupational blood and body fluid exposures in health care workers in Guizhou, China: A structural equation modeling approachAmerican Journal of Infection Control 2015; 43(11): e73 doi: 10.1016/j.ajic.2015.07.014
3
Arghavan Asghari, Fatemeh Jafari, Maryam Jameshorani, Hossein Chiti, Mohsen Naseri, Anahita Ghafourirankouhi, Omid Kooshkaki, Alireza Abdshah, Negin Parsamanesh. Vitamin D role in hepatitis B: focus on immune system and genetics mechanismHeliyon 2022; 8(11): e11569 doi: 10.1016/j.heliyon.2022.e11569
4
Hyosun Cho, Hyojeung Kang, Hwan Lee, Chang Kim. Programmed Cell Death 1 (PD-1) and Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) in Viral HepatitisInternational Journal of Molecular Sciences 2017; 18(7): 1517 doi: 10.3390/ijms18071517
5
Yong Zhao, Ling Xiang Kong, Feng Shi Feng, Jiayin Yang, Guo Wei. A simple CD4+ T cells to FIB-4 ratio for evaluating prognosis of BCLC-B hepatocellular carcinoma: a retrospective cohort studyBMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09433-3
6
I. P. Balmasova, R. I. Sepiashvili, E. S. Malova. MOLECULAR BIOLOGY OF HEPATITIS B VIRUS AND IMMUNOPATHOGENESIS OF CHRONIC VIRAL HEPATITIS BJournal of microbiology, epidemiology and immunobiology 2016; 93(2): 119 doi: 10.36233/0372-9311-2016-2-119-126
7
L. Boglione, A. D'Avolio, G. Cariti, M. G. Milia, M. Simiele, A. De Nicolò, V. Ghisetti, G. Di Perri. Sequential therapy with entecavir and PEG‐INF in patients affected by chronic hepatitis B and high levels of HBV‐DNA with non‐D genotypesJournal of Viral Hepatitis 2013; 20(4) doi: 10.1111/jvh.12018
8
Prashant Pandey, Divya Setya, Shweta Ranjan, Supriya Kumari, Dharmender Kumar. Correlation between Hepatitis B Viral Load and Hepatitis B Surface Antigen Levels in Asymptomatic Seropositive Blood DonorsGlobal Journal of Transfusion Medicine 2023; 8(2): 186 doi: 10.4103/gjtm.gjtm_12_23
9
R. S. Pandey, V. K. Dixit. Evaluation of ISCOM vaccines for mucosal immunization against hepatitis BJournal of Drug Targeting 2010; 18(4): 282 doi: 10.3109/10611860903450015
10
Irina P Balmasova, Nikolay D Yushchuk, Ospan A Mynbaev, Nageswara R Alla, Elena S Malova, Zhongjie Shi, Chang-Lu Gao. Immunopathogenesis of chronic hepatitis BWorld Journal of Gastroenterology 2014; 20(39): 14156-14171 doi: 10.3748/wjg.v20.i39.14156
11
Hui Zhang, Jianchun Xian, Yang Li, Li Xiao, Lu Wang, Muhammad Zia-Ul-Haq. Effects of Tenofovir Combined with Recombinant Human Interferon α-2b on Negative Conversion Rate, Liver Function, Immune Status, and Drug Safety in Patients with Chronic Hepatitis B: A Systematic Review and Meta-AnalysisEvidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/1889628
12
Christian A. Engell, Vinh Philip Pham, Robert S. Holzman, Judith A. Aberg. Virologic Outcome of Using Tenofovir/Emtricitabine to Treat Hepatitis B in HIV-Coinfected PatientsISRN Gastroenterology 2011; 2011: 1 doi: 10.5402/2011/405390
13
Apostolos Koffas, Manoj Kumar, Upkar S. Gill, Ankur Jindal, Patrick T. F. Kennedy, S. K. Sarin. Chronic hepatitis B: the demise of the ‘inactive carrier’ phaseHepatology International 2021; 15(2): 290 doi: 10.1007/s12072-021-10137-2
14
Marina Manea, Ion Mărunțelu, Ileana Constantinescu. Extended analysis on peripheral blood cytokines correlated with hepatitis B virus viral load in chronically infected patients – a systematic review and meta-analysisFrontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1429926
15
Ayaid Khadem Zgair, Jenan A. Ghafil, Razaq H E Al‐Sayidi. Direct role of antibody‐secreting B cells in the severity of chronic hepatitis BJournal of Medical Virology 2015; 87(3): 407 doi: 10.1002/jmv.24067
16
Nesa Shokoohifar, Salman Ahmady-Asbchin, Sima Besharat, Fatemeh Roudbari, Saeed Mohammadi, Taghi Amiriani, Behnaz Khodabakhshi, Alireza Norouzi, Iman Shahabinasab. The Impaired Balance of CD4+/CD8+ Ratio in Patients with Chronic Hepatitis BHepatitis Monthly 2020; 20(1) doi: 10.5812/hepatmon.96799
17
He Liu, Mei Li, Mingjuan Jin, Fangyuan Jing, Hui Wang, Kun Chen. Public awareness of three major infectious diseases in rural Zhejiang province, China: a cross-sectional studyBMC Infectious Diseases 2013; 13(1) doi: 10.1186/1471-2334-13-192
18
Lucio Boglione, Jessica Cusato, Giuseppe Cariti, Giovanni Di Perri, Antonio D'Avolio. The E genotype of hepatitis B: Clinical and virological characteristics, and response to interferonJournal of Infection 2014; 69(1): 81 doi: 10.1016/j.jinf.2014.02.018
19
Hongyan Wang, Di Wu, Xiaofeng Wang, Guang Chen, Yuanya Zhang, Weiming Yan, Xiaoping Luo, Meifang Han, Qin Ning. Hepatitis B virus surface protein-induced hPIAS1 transcription requires TAL1, E47, MYOG, NFI, and MAPK signal pathwaysBiological Chemistry 2016; 397(11): 1173 doi: 10.1515/hsz-2015-0290
20
Sukriti Sukriti, Nirupma Trehan Pati, Sujoy Bose, Syed S. Hissar, Shiv Kumar Sarin. Impaired Antigen Processing and Presentation Machinery is Associated with Immunotolerant State in Chronic Hepatitis B Virus InfectionJournal of Clinical Immunology 2010; 30(3): 419 doi: 10.1007/s10875-010-9379-4